Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Growth

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -35.99-579.49-62.36150.21-353.26

What is the latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Growth ratio of OXYGENTA PHARMACEUTICAL is -35.99 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024-35.99
Mar2023-579.49
Mar2022-62.36
Mar2021150.21
Mar2020-353.26

How is Core EBITDA Growth of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Growth % Change
Mar2024 -35.99
Negative
Mar2023 -579.49
Negative
Mar2022 -62.36
Negative
Mar2021 150.21
Positive
Mar2020 -353.26 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Growth ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹228.2 Cr -10.6% -15.8% -16.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,894.0 Cr 1.5% 4% -14.3% Stock Analytics
DIVIS LABORATORIES ₹162,781.0 Cr 4.5% 2.2% 13.4% Stock Analytics
CIPLA ₹122,179.0 Cr -0.2% -2.5% -8% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,118.0 Cr 1% -2.6% 4.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,964.0 Cr -0.2% -3.7% -6.6% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-10.6%

-15.8%

-16.1%

SENSEX

1.5%

1.7%

0.6%


You may also like the below Video Courses